Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 354671, 6 pages
http://dx.doi.org/10.1155/2015/354671
Review Article

Metabolomics for Biomarker Discovery: Moving to the Clinic

National TCM Key Lab of Serum Pharmacochemistry, Laboratory of Metabolomics and Chinmedomics, Department of Pharmaceutical Analysis, Heilongjiang University of Chinese Medicine, Heping Road 24, Harbin 150040, China

Received 3 August 2014; Accepted 28 December 2014

Academic Editor: Fa-Yun Che

Copyright © 2015 Aihua Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Tomita and K. Kami, “Systems biology, metabolomics, and cancer metabolism,” Science, vol. 336, no. 6084, pp. 990–991, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Zhang, H. Sun, and X. Wang, “Saliva metabolomics opens door to biomarker discovery, disease diagnosis, and treatment,” Applied Biochemistry and Biotechnology, vol. 168, no. 6, pp. 1718–1727, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Tsutsui, T. Maeda, J. Z. Min et al., “Biomarker discovery in biological specimens (plasma, hair, liver and kidney) of diabetic mice based upon metabolite profiling using ultra-performance liquid chromatography with electrospray ionization time-of-flight mass spectrometry,” Clinica Chimica Acta, vol. 412, no. 11-12, pp. 861–872, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Zhang, H. Sun, G. Yan, P. Wang, Y. Han, and X. Wang, “Metabolomics in diagnosis and biomarker discovery of colorectal cancer,” Cancer Letters, vol. 345, no. 1, pp. 17–20, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. J. A. Haviland, M. Tonelli, D. T. Haughey, W. P. Porter, and F. M. Assadi-Porter, “Novel diagnostics of metabolic dysfunction detected in breath and plasma by selective isotope-assisted labeling,” Metabolism: Clinical and Experimental, vol. 61, no. 8, pp. 1162–1170, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Tenori, C. Oakman, W. M. Claudino et al., “Exploration of serum metabolomic profiles and outcomes in women with metastatic breast cancer: a Pilot Study,” Molecular Oncology, vol. 6, no. 4, pp. 437–444, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Yoshida, N. Hatano, S. Nishiumi et al., “Diagnosis of gastroenterological diseases by metabolome analysis using gas chromatography-mass spectrometry,” Journal of Gastroenterology, vol. 47, no. 1, pp. 9–20, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Zhang, H. Sun, X. Wu, and X. Wang, “Urine metabolomics,” Clinica Chimica Acta, vol. 414, pp. 65–69, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. A. K. Arakaki, J. Skolnick, and J. F. McDonald, “Marker metabolites can be therapeutic targets as well,” Nature, vol. 456, no. 7221, p. 443, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Zhang, X. Wu, M. Yin et al., “Discrimination between malignant and benign ovarian tumors by plasma metabolomic profiling using ultra performance liquid chromatography/mass spectrometry,” Clinica Chimica Acta, vol. 413, no. 9-10, pp. 861–868, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Zhang, H. Sun, Y. Han et al., “Exploratory urinary metabolic biomarkers and pathways using UPLC-Q-TOF-HDMS coupled with pattern recognition approach,” Analyst, vol. 137, no. 18, pp. 4200–4208, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Yuan, S. B. Breitkopf, X. Yang, and J. M. Asara, “A positive/negative ion-switching, targeted mass spectrometry-based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue,” Nature Protocols, vol. 7, no. 5, pp. 872–881, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. J. K. Nicholson and I. D. Wilson, “Understanding 'global' systems biology: metabonomics and the continuum of metabolism,” Nature Reviews Drug Discovery, vol. 2, no. 8, pp. 668–676, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Chen, J. Xue, L. Zhou, S. Wu, and Z. Chen, “Identification of serum biomarkers of hepatocarcinoma through liquid chromatography/mass spectrometry-based metabonomic method,” Analytical and Bioanalytical Chemistry, vol. 401, no. 6, pp. 1899–1904, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. H. M. Woo, K. M. Kim, M. H. Choi et al., “Mass spectrometry based metabolomic approaches in urinary biomarker study of women's cancers,” Clinica Chimica Acta, vol. 400, no. 1-2, pp. 63–69, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. A. D. Patterson, O. Maurhofer, D. Beyoglu et al., “Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profiling,” Cancer Research, vol. 71, no. 21, pp. 6590–6600, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Holmes, R. L. Loo, J. Stamler et al., “Human metabolic phenotype diversity and its association with diet and blood pressure,” Nature, vol. 453, no. 7193, pp. 396–400, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. T. J. Wang, M. G. Larson, R. S. Vasan et al., “Metabolite profiles and the risk of developing diabetes,” Nature Medicine, vol. 17, no. 4, pp. 448–453, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. S. F. Graham, O. P. Chevallier, D. Roberts, C. Hölscher, C. T. Elliott, and B. D. Green, “Investigation of the human brain metabolome to identify potential markers for early diagnosis and therapeutic targets of Alzheimer's disease,” Analytical Chemistry, vol. 85, no. 3, pp. 1803–1811, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Ibáñez, C. Simó, P. J. Martín-Álvarez et al., “Toward a predictive model of Alzheimer's disease progression using capillary electrophoresis-mass spectrometry metabolomics,” Analytical Chemistry, vol. 84, no. 20, pp. 8532–8540, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Mapstone, A. K. Cheema, M. S. Fiandaca et al., “Plasma phospholipids identify antecedent memory impairment in older adults,” Nature Medicine, vol. 20, no. 4, pp. 415–418, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. J. F. Xiao, R. S. Varghese, B. Zhou et al., “LC-MS based serum metabolomics for identification of hepatocellular carcinoma biomarkers in Egyptian cohort,” Journal of Proteome Research, vol. 11, no. 12, pp. 5914–5923, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. B. Wang, D. Chen, Y. Chen et al., “Metabonomic profiles discriminate hepatocellular carcinoma from liver cirrhosis by ultraperformance liquid chromatography-mass spectrometry,” Journal of Proteome Research, vol. 11, no. 2, pp. 1217–1227, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Tan, P. Yin, L. Tang et al., “Metabolomics study of stepwise hepatocarcinogenesis from the model rats to patients: potential biomarkers effective for small hepatocellular carcinoma diagnosis,” Molecular & Cellular Proteomics, vol. 11, no. 2, Article ID M111.010694, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Chen, G. Xie, X. Wang et al., “Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma,” Molecular & Cellular Proteomics, vol. 10, no. 7, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Shao, B. Zhu, R. Zheng et al., “Development of urinary pseudotargeted LC-MS-based metabolomics method and its application in hepatocellular carcinoma biomarker discovery,” Journal of Proteome Research, 2014. View at Publisher · View at Google Scholar
  27. W. Dai, P. Yin, P. Chen et al., “Study of urinary steroid hormone disorders: difference between hepatocellular carcinoma in early stage and cirrhosis,” Analytical and Bioanalytical Chemistry, vol. 406, no. 18, pp. 4325–4335, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Qi, X. Ouyang, L. Wang, W. Peng, J. Wen, and Y. Dai, “A pilot metabolic profiling study in serum of patients with chronic kidney disease based on 1H-NMR-spectroscopy,” Clinical and Translational Science, vol. 5, no. 5, pp. 379–385, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Y. Zhao, “Metabolomics in chronic kidney disease,” Clinica Chimica Acta, vol. 422, pp. 59–69, 2013. View at Publisher · View at Google Scholar
  30. K. Vouk, N. Hevir, M. Ribič-Pucelj et al., “Discovery of phosphatidylcholines and sphingomyelins as biomarkers for ovarian endometriosis,” Human Reproduction, vol. 27, no. 10, pp. 2955–2965, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. I. Bertini, S. Cacciatore, B. V. Jensen et al., “Metabolomic NMR fingerprinting to identify and predict survival of patients with metastatic colorectal cancer,” Cancer Research, vol. 72, no. 1, pp. 356–364, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. L. Lin, Z. Huang, Y. Gao, X. Yan, J. Xing, and W. Hang, “LC-MS based serum metabonomic analysis for renal cell carcinoma diagnosis, staging, and biomarker discovery,” Journal of Proteome Research, vol. 10, no. 3, pp. 1396–1405, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Jung, S.-H. Kim, H.-S. Lee et al., “Serum metabolomics reveals pathways and biomarkers associated with asthma pathogenesis,” Clinical and Experimental Allergy, vol. 43, no. 4, pp. 425–433, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Xu, Y. Chen, R. Zhang et al., “Global and targeted metabolomics of esophageal squamous cell carcinoma discovers potential diagnostic and therapeutic biomarkers,” Molecular & Cellular Proteomics, vol. 12, no. 5, pp. 1306–1318, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. C.-W. Lam and C.-Y. Law, “Untargeted mass spectrometry-based metabolomic profiling of pleural effusions: fatty acids as novel cancer biomarkers for malignant pleural effusions,” Journal of Proteome Research, vol. 13, no. 9, pp. 4040–4046, 2014. View at Publisher · View at Google Scholar
  36. J. V. de Seymour, C. A. Conlon, K. Sulek et al., “Early pregnancy metabolite profiling discovers a potential biomarker for the subsequent development of gestational diabetes mellitus,” Acta Diabetologica, vol. 51, no. 5, pp. 887–890, 2014. View at Publisher · View at Google Scholar
  37. A. Zhang, H. Sun, and X. Wang, “Serum metabolomics as a novel diagnostic approach for disease: a systematic review,” Analytical and Bioanalytical Chemistry, vol. 404, no. 4, pp. 1239–1245, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Zhang, H. Sun, G. Yan, Y. Han, Y. Ye, and X. Wang, “Urinary metabolic profiling identifies a key role for glycocholic acid in human liver cancer by ultra-performance liquid-chromatography coupled with high-definition mass spectrometry,” Clinica Chimica Acta, vol. 418, pp. 86–90, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. H. Sun, A. Zhang, G. Yan et al., “Metabolomic analysis of key regulatory metabolites in hepatitis C virus-infected tree shrews,” Molecular and Cellular Proteomics, vol. 12, no. 3, pp. 710–719, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. X. Wang, A. Zhang, Y. Han et al., “Urine metabolomics analysis for biomarker discovery and detection of Jaundice syndrome in patients with liver disease,” Molecular and Cellular Proteomics, vol. 11, no. 8, pp. 370–380, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. A.-H. Zhang, H. Sun, S. Qiu, and X.-J. Wang, “Metabolomics in noninvasive breast cancer,” Clinica Chimica Acta, vol. 424, pp. 3–7, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. I. Rowe, M. Chiaravalli, V. Mannella et al., “Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy,” Nature Medicine, vol. 19, no. 4, pp. 488–493, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Zhang, H. Sun, and X. Wang, “Urinary metabolic profiling of rat models revealed protective function of scoparone against alcohol induced hepatotoxicity,” Scientific Reports, vol. 4, article 6768, 2014. View at Publisher · View at Google Scholar